Cabezas-Camarero S, Alonso-Ovies A, Merino-Menendez S, Cabrera-Martin MN, et al. Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer. Oral Oncol 2021;123:105589.
PMID: 34742008